2024-07-13 06:56:10 ET
Summary
- Repligen's Q1 revenue declined by 20% organically, driven by Covid-related business decline and reduced demand in China and protein business.
- Strong growth and pipelines in the core filtration business, with non-Covid filtration revenue surging by more than 15% in Q1.
- FY24 outlook includes -1% to +4% base revenue growth, with expectations of industry recovery in the second half of 2024 and a one-year price target of $150 per share.
...
Read the full article on Seeking Alpha
For further details see:
Repligen: Strong Filtration Growth, Offset By Other Challenges